FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approves a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk. The action updates the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

SUPPL AP for LEVEMIR (INSULIN DETEMIR)